BidaskClub upgraded shares of Express Scripts (NASDAQ:ESRX) from a hold rating to a buy rating in a research report released on Thursday morning.

Several other research analysts also recently issued reports on ESRX. Jefferies Group set a $72.00 price target on shares of Express Scripts and gave the stock a buy rating in a report on Tuesday, August 29th. Robert W. Baird reiterated a hold rating and set a $56.00 price target on shares of Express Scripts in a report on Friday, September 1st. ValuEngine downgraded shares of Express Scripts from a buy rating to a hold rating in a report on Friday, September 1st. Royal Bank of Canada initiated coverage on shares of Express Scripts in a report on Tuesday, September 19th. They set a sector perform rating and a $68.00 price target for the company. Finally, UBS downgraded shares of Express Scripts from a market perform rating to an underperform rating in a report on Monday, October 9th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Express Scripts has an average rating of Hold and an average target price of $74.40.

Shares of Express Scripts (NASDAQ ESRX) traded up $2.53 on Thursday, reaching $71.55. 8,786,136 shares of the company’s stock traded hands, compared to its average volume of 4,094,484. Express Scripts has a 1-year low of $55.80 and a 1-year high of $73.42. The firm has a market capitalization of $40,523.99, a P/E ratio of 10.46, a P/E/G ratio of 1.06 and a beta of 0.88. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same period in the previous year, the business earned $1.74 earnings per share. The company’s revenue was down 2.9% on a year-over-year basis. equities analysts expect that Express Scripts will post 7.02 earnings per share for the current year.

In other news, CEO Timothy C. Wentworth purchased 8,000 shares of the business’s stock in a transaction on Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. Insiders own 0.68% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the business. Burt Wealth Advisors boosted its position in Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after acquiring an additional 174 shares during the last quarter. CKW Financial Group boosted its position in Express Scripts by 20.0% during the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after acquiring an additional 300 shares during the last quarter. Bank of Nova Scotia Trust Co. bought a new stake in Express Scripts during the third quarter valued at $120,000. First Personal Financial Services boosted its position in Express Scripts by 199.1% during the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after acquiring an additional 1,400 shares during the last quarter. Finally, Monroe Bank & Trust MI boosted its position in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the last quarter. 88.44% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Express Scripts (ESRX) Lifted to “Buy” at BidaskClub” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/17/express-scripts-esrx-lifted-to-buy-at-bidaskclub.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related stocks with our FREE daily email newsletter.